SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : wla(warner lambert) -- Ignore unavailable to you. Want to Upgrade?


To: Captain Jack who wrote (836)6/17/1999 5:33:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 942
 
Analyst ratings issued today:

Bear Stearns
reiterates buy, announced the Pfizers
migraine drug, Relpak was selected
as the quid for the Lipitor
co-promotion as part of an
arrangement between the firms.

Gruntal & Co. reiterates buy based on Rezulin news.

P.S. Captain, glad you're feeling less pessimistic towards WLA. As I see it, overhead resistance at $65, $67-ish, and $71. Perhaps the worst is over?